W. R. Grace & Co., operating as Grace, is a global leader in specialty chemicals and engineered materials. The company manufactures high-performance catalysts, silica-based products, process technologies, and fine chemicals that enable customers in refining, petrochemical, pharmaceutical, and consumer industries to produce everyday goods more efficiently and sustainably.
Its Catalysts Technologies business supplies fluid catalytic cracking (FCC) catalysts and additives, hydroprocessing catalysts, and polyolefin catalysts and licensing technologies used in fuel production, plastics manufacturing, and renewable energy applications. The Materials Technologies segment provides specialty silicas, matting agents, and additives for coatings, pharmaceuticals, food packaging, personal care, and industrial uses. Grace also offers fine chemical manufacturing services as a North American CDMO for active pharmaceutical ingredients and intermediates.
Headquartered in Columbia, Maryland, Grace maintains a global network of manufacturing plants, R&D centers, and offices spanning North America, Latin America, Europe, and Asia, with customers in more than 60 countries. It employs several thousand people and holds thousands of patents. Since its 2021 acquisition by Standard Industries, Grace operates as a private company and flagship of the Performance Materials platform, strengthening its position through further acquisitions such as full ownership of the ART Hydroprocessing joint venture in 2025.
With over 165 years of history tracing back to its 1854 founding, Grace is recognized as a market leader in FCC and polyolefin catalysts, specialty silica gels, and related technologies, supporting critical value chains while emphasizing innovation, safety, and sustainability.
Also known as Pieri S.A.S., W.R. Grace & Co.-Conn., WR Grace, Grace Specialty Chemicals, Grace Construction Products, W.R. Grace & Co., Pieri SAS, and Pieri.
chemXplore tracks 4 projects involving Grace.
Grace's role on them: Owner, Investor / Financier, Operator, Developer, and Technology / equipment supplier.
Multi-year partnership uses AI-driven retrosynthesis and microliter high-throughput experiments to speed scalable synthesis of peptide building blocks and relieve GLP‑1 supply-chain bottlenecks.
Expands hydroprocessing catalyst range for resid and distillate hydrotreating and renewables fuels; preserves exclusive supplier role to a process licensor for newly licensed units.
AI retrosynthesis platform chosen from 30+ entrants to speed molecule development and scale-up; multiple runners-up received cash prizes.
25% more capacity with a 4,000-gallon HASTELLOY centrifuge and three 4,000-gallon reactors to boost API, RSM and intermediate production from R&D through commercial supply under cGMP.
The new plant in Worms will boost LUDOX® colloidal silica capacity, support high-demand applications, and enhance logistics for Europe, the Middle East, and Asia, completing in Q2 2020.
The Worms facility will expand to boost polypropylene catalyst production, starting construction in Q1 2010. The site, with 900 employees, is ISO 14001 certified and supports various industries.
By country, the most active first. active / all projects
